However, this mechanism suggests that hypoxia should benefit all complex I-linked mitochondrial diseases that similarly compromise the rate of catalysis, not be specific to a particular subset (including the ndufs4−/− family) or a specific genetic background (or species). The gene discussed is NDUFS4; the disease is inborn mitochondrial metabolism disorder.